Relevant bibliographies by topics / Cystic fibrosis

Academic literature on the topic 'Cystic fibrosis'

Author: Grafiati
Published: 4 June 2021
Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cystic fibrosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cystic fibrosis"

1

Marin, Angelica-Cristina, Dana-Teodora Anton-Păduraru, Nicoleta-Bianca Cloşcă, Doina Mihăilă, and Marin Burlea. "Cystic fibrosis and Helicobacter pylori infection." Romanian Journal of Infectious Diseases 19, no. 2 (June 30, 2016): 54–59. http://dx.doi.org/10.37897/rjid.2016.2.2.

Full text
Abstract:
Helicobacter pylori infection is the most frequent bacterian infection and the main cause of duodenal ulcerations. The prevalence in patients with cysic fibrosis is controversial. The paper present generale data about Helicobacter pylori and the particularities of this infection in cystic fibrosis (cystic fibrosis paradox). The authors concluded that although the prevalence of Helicobacter pylori and its role in gastroduodenal disease in cystic fibrosis are controversial, however, its role should not be underestimated.
APA, Harvard, Vancouver, ISO, and other styles
2

Jones, Andrew. "Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis." Seminars in Respiratory and Critical Care Medicine 36, no. 02 (March 31, 2015): 167–68. http://dx.doi.org/10.1055/s-0035-1547317.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

&NA;. "Cystic fibrosis and fibrosing colonopathy." Advances in Anatomic Pathology 3, no. 2 (March 1996): 112. http://dx.doi.org/10.1097/00125480-199603000-00015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Smyth, R. L. "Fibrosing colonopathy in cystic fibrosis." Archives of Disease in Childhood 74, no. 5 (May 1, 1996): 464–68. http://dx.doi.org/10.1136/adc.74.5.464.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

LYON, IAN C. T., and DIANNE R. WEBSTER. "Newborn Screening for Cystic Fibrosis." Pediatrics 87, no. 6 (June 1, 1991): 954–55. http://dx.doi.org/10.1542/peds.87.6.954.

Full text
Abstract:
To the Editor.— The report on newborn screening for cystic fibrosis1 illustrates the need for continued evaluation of such programs. The authors state that the identification of cases of cystic fibrosis (CF) by an elevated level of immunoreactive trypsinogen (IRT) in second (follow-up) samples from infants with positive initial screening tests could result in false negatives in 27% of cases of cystic fibrosis without meconium ileus (MI). We have screened 401 122 infants using the method originally reported.2
APA, Harvard, Vancouver, ISO, and other styles
6

Grody, Wayne W. "Cystic Fibrosis." Archives of Pathology & Laboratory Medicine 123, no. 11 (November 1, 1999): 1041–46. http://dx.doi.org/10.5858/1999-123-1041-cf.

Full text
Abstract:
Abstract Objective.—To review the current status of scientific knowledge and opinion regarding molecular genetic testing of mutations in the CFTR gene for purposes of diagnosis and population carrier screening of cystic fibrosis (CF). Data Sources.—Published research findings on the nature of the CFTR gene, pilot population screening studies in the United States and Europe, and ongoing deliberations of professional and governmental agencies considering implementation of widespread testing. Study Selection.—Findings relevant to the molecular heterogeneity of CFTR mutations and its implications for population carrier screening were considered. Data Extraction.—Information was extracted from studies published by us and others, as made available to recent consensus panels and professional committees. Data Synthesis.—These data were reevaluated in light of recent movements in professional and public policy regarding acceptability and desirability of widespread CF mutation testing. Effects to date of such testing on patient outcomes is reported. Conclusions.—The ability to test for CFTR mutations at the molecular level has already improved the diagnosis of symptomatic patients and expanded the reproductive options of family members of CF patients. The same technology also holds promise of identifying asymptomatic carriers and at-risk couples without family history in the general population so that they too might be offered prenatal diagnosis or other options. However, a number of key questions remain to be worked out before a widespread national screening program can be put into practice. These include the target population to be offered testing (the entire population vs high-risk ethnic groups), the size and nature of the mutation test panel (universal vs ethnic specific), the inclusion or exclusion of CFTR variants that do not cause classical CF, the optimal testing technology, appropriate standards for laboratory quality assurance, and the development of sufficient educational materials and genetic counseling resources for test delivery, reporting, and interpretation. The answers to these questions will be relevant not only to CF testing but also to many other large-scale molecular genetic screening programs being considered in the future.
APA, Harvard, Vancouver, ISO, and other styles
7

Wendekier, Camille, and Katheryn Wendekier-Raybuck. "Cystic fibrosis." Nursing 51, no. 6 (June 2021): 32–38. http://dx.doi.org/10.1097/01.nurse.0000751344.57701.75.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Davis, P. B. "Cystic Fibrosis." Pediatrics in Review 22, no. 8 (August 1, 2001): 257–64. http://dx.doi.org/10.1542/pir.22-8-257.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Montgomery, G. S., and M. Howenstine. "Cystic Fibrosis." Pediatrics in Review 30, no. 8 (July 31, 2009): 302–10. http://dx.doi.org/10.1542/pir.30-8-302.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Paranjape, S. M., and P. J. Mogayzel. "Cystic Fibrosis." Pediatrics in Review 35, no. 5 (May 1, 2014): 194–205. http://dx.doi.org/10.1542/pir.35-5-194.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Cystic fibrosis"

1

Chadwick, Helen Kay. "Cognitive function in cystic fibrosis and cystic fibrosis related diabetes (CFRD)." Thesis, University of Leeds, 2016. http://etheses.whiterose.ac.uk/16912/.

Full text
Abstract:
Cystic fibrosis (CF) is a complex multisystem disease caused by a gene mutation of a protein called the CF Transmembrane Conductance Regulator (CFTR). Glucose tolerance abnormalities are common in CF and the prevalence of CF related diabetes (CFRD), which shares clinical characteristics with type 1 (T1DM) and type 2 diabetes (T2DM), increases with age. Impaired glucose tolerance (IGT), T1DM and T2DM are associated with cognitive impairment relative to healthy controls. The overall aim of this thesis was to examine cognitive function in CF. Study 1 investigated the impact of CF on cognitive function, in people with CFRD (n=49), people with CF who are not diabetic (CFND, n=49) and healthy controls (n=49). Memory, attention and processing speed, and cognitive flexibility was impaired in CFRD, and to a lesser degree in CFND, relative to healthy controls. Study 2 assessed cognitive function over a 1-3 year period in people with CFRD (N=36) and found no evidence of cognitive decline despite a decline in lung function. Study 3 compared cognitive function in people with CFRD who were post transplant (CFRDTx, n=18), people with CFRD (who were not post transplant, n=18), and healthy controls (n=18). CFRD was associated with impairment in attention and processing speed, spatial working memory, cognitive flexibility and to a lesser extent verbal memory. Cognitive function did not improve post transplantation in people with CFRD. Study 4 followed up people with CFRDTx (N=8) over an 18±6 month period and found no decline in cognitive function. Taken together, the evidence presented in this thesis suggests that diabetes in CF is associated with cognitive impairment, and that maintaining glycaemic control protects against cognitive decline. The cognitive impairment observed in people with CF is of clinical significance and has implications for self care and disease management. The recent discovery that CFTR is present in the pancreas and the brain has important implications for the effects of the new CFTR potentiator and corrector therapies on cognitive function in CF.
APA, Harvard, Vancouver, ISO, and other styles
2

Kahre, Tiina. "Cystic fibrosis in Estonia /." Online version, 2004. http://dspace.utlib.ee/dspace/bitstream/10062/577/5/KahrePhD.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dwyer, Tiffany Jane. "Exercise in cystic fibrosis." Thesis, The University of Sydney, 2010. http://hdl.handle.net/2123/6349.

Full text
Abstract:
Exercise and physical activity have many benefits for adults with cystic fibrosis (CF), including the potential to aid mucus clearance, improve lung function, exercise capacity and quality of life. Despite the recommendations from consensus documents for CF adults to engage in regular physical activity, exercise participation amongst this population is often very low. No in-depth study has been undertaken to explore the determinants of exercise participation for this group and no studies have examined the benefits of habitual physical activity on the health status and quality of life of CF adults. As well, the current methods to quantify physical activity are problematic. The series of studies, involving CF adults, in this thesis was therefore undertaken in order to examine the physiological rationale for the use of exercise as an airway clearance technique, to understand the decision making process to engage in exercise, to determine if health status and quality of life were affected by exercise participation, and to establish the accuracy of a recently-developed objective measure of physical activity. The study in Chapter 2 provided some physiological rationale for choosing treadmill exercise to aid airway clearance in CF. The main findings were that a single bout of moderate intensity exercise increased the subjective ease of expectoration, most likely due to the increased ventilation with exercise, and that sputum viscoelasticity was favourably decreased immediately following treadmill exercise compared to cycle exercise and control. The studies in Chapters 3 and 4 identified the main beliefs regarding exercise for CF adults and highlighted that the main predictors of exercise intention and participation for this group were aspects of perceived and actual control to exercise, namely self-efficacy or confidence to exercise, feeling healthy, receiving encouragement to exercise, and rating exercise as a high priority treatment. Positive ratings of these aspects of control either increased exercise participation directly, indirectly by increasing intention, or strengthened the conversion of exercise intention to participation. Strategies aimed at targeting these aspects of control are therefore likely to be effective in increasing exercise participation for CF adults. The study in Chapter 5 demonstrated that CF adults, who reportedly performed at least 90 minutes of moderate to strenuous exercise per week, had significantly higher quality of life and fewer days in hospital over the following year than their peers, who exercised less. The difference in hospitalisation between the CF adults, who reportedly exercised more than 90 minutes per week and those who did not, was independent of baseline lung function, and the females who reportedly performed less than 90 minutes of exercise per week had three times as many days in hospital than their high-activity peers. The study in Chapter 6 showed that the SenseWear Pro3 Armband activity monitor provided a reasonable estimate of energy expenditure and step count. Also, its accuracy was not affected by diagnosis with CF, despite the potential for the high salt content in the sweat to interfere with the device’s physiological sensors placed on the skin. Overall, this series of studies adds to the growing evidence of the physical and psychological benefits from exercise participation for CF adults, as well as providing some empirical evidence upon which to base strategies to improve exercise participation for this group and support for an objective measure of physical activity.
APA, Harvard, Vancouver, ISO, and other styles
4

Dwyer, Tiffany Jane. "Exercise in cystic fibrosis." Discipline of Physiotherapy, Faculty of Health Sciences, University of Sydney, 2010. http://hdl.handle.net/2123/6349.

Full text
Abstract:
Doctor of Philosophy (PhD)
Exercise and physical activity have many benefits for adults with cystic fibrosis (CF), including the potential to aid mucus clearance, improve lung function, exercise capacity and quality of life. Despite the recommendations from consensus documents for CF adults to engage in regular physical activity, exercise participation amongst this population is often very low. No in-depth study has been undertaken to explore the determinants of exercise participation for this group and no studies have examined the benefits of habitual physical activity on the health status and quality of life of CF adults. As well, the current methods to quantify physical activity are problematic. The series of studies, involving CF adults, in this thesis was therefore undertaken in order to examine the physiological rationale for the use of exercise as an airway clearance technique, to understand the decision making process to engage in exercise, to determine if health status and quality of life were affected by exercise participation, and to establish the accuracy of a recently-developed objective measure of physical activity. The study in Chapter 2 provided some physiological rationale for choosing treadmill exercise to aid airway clearance in CF. The main findings were that a single bout of moderate intensity exercise increased the subjective ease of expectoration, most likely due to the increased ventilation with exercise, and that sputum viscoelasticity was favourably decreased immediately following treadmill exercise compared to cycle exercise and control. The studies in Chapters 3 and 4 identified the main beliefs regarding exercise for CF adults and highlighted that the main predictors of exercise intention and participation for this group were aspects of perceived and actual control to exercise, namely self-efficacy or confidence to exercise, feeling healthy, receiving encouragement to exercise, and rating exercise as a high priority treatment. Positive ratings of these aspects of control either increased exercise participation directly, indirectly by increasing intention, or strengthened the conversion of exercise intention to participation. Strategies aimed at targeting these aspects of control are therefore likely to be effective in increasing exercise participation for CF adults. The study in Chapter 5 demonstrated that CF adults, who reportedly performed at least 90 minutes of moderate to strenuous exercise per week, had significantly higher quality of life and fewer days in hospital over the following year than their peers, who exercised less. The difference in hospitalisation between the CF adults, who reportedly exercised more than 90 minutes per week and those who did not, was independent of baseline lung function, and the females who reportedly performed less than 90 minutes of exercise per week had three times as many days in hospital than their high-activity peers. The study in Chapter 6 showed that the SenseWear Pro3 Armband activity monitor provided a reasonable estimate of energy expenditure and step count. Also, its accuracy was not affected by diagnosis with CF, despite the potential for the high salt content in the sweat to interfere with the device’s physiological sensors placed on the skin. Overall, this series of studies adds to the growing evidence of the physical and psychological benefits from exercise participation for CF adults, as well as providing some empirical evidence upon which to base strategies to improve exercise participation for this group and support for an objective measure of physical activity.
APA, Harvard, Vancouver, ISO, and other styles
5

Utley, Courtney, and Kristen L. McHenry. "Advances in Cystic Fibrosis." Digital Commons @ East Tennessee State University, 2016. https://dc.etsu.edu/etsu-works/2546.

Full text
Abstract:
The purpose of this review was to identify the history of and advances in cystic fibrosis (CF). New treatment plans, medication developments, and a historical perspective of airway clearance therapy (ACT) will be presented. The importance of treatment compliance and time management in the care of cystic fibrosis patients will also be discussed. Furthermore, the development of cystic fibrosis clinics and the pivotal role they play in the treatment of the disease will be addressed. Lastly, a brief discussion concerning the need for and process of lung transplantation will be reported.
APA, Harvard, Vancouver, ISO, and other styles
6

Dobson, Lee. "Glucose tolerance in cystic fibrosis." Thesis, University of Exeter, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.403679.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hurley, Matthew. "Lung infection in cystic fibrosis." Thesis, University of Nottingham, 2016. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.716679.

Full text
Abstract:
Cystic fibrosis (CF) is characterised by viscid secretions that, in the lungs, pre-dispose to infection. Many people with CF experience 'pulmonary exacerbations' accompanied by intermittent deteriorations in lung function. Pulmonary exacerbations are associated with a more rapid decline in lung health over time and are associated with infection. Early infection managed aggressively may be successfully eradicated. With successive infections and cumulative lung damage, chronic infection is established. Chronic infection leads to progressive decline in lung function with associated reductions in quality of life and increased treatment burden, morbidity and mortality. Naturally antibiotic-tolerant organisms that evolve resistance to commonly used antibiotics are problematic, in particular Pseudomonas aeruginosa. As is the case with other organisms that cause lung infection in those with CF, P. aeruginosa's antibiotic tolerance and ability to establish chronic infection is thought to be conferred through the biofilm mode of growth. The adaptability of the organism to pressures exerted by antibiotics and competition within the lung environment promote antibiotic resistance. New strategies effective in preventing and managing chronic infection are likely to yield improvement in survival and quality of life, however the development of such agents is yet to materialise.
APA, Harvard, Vancouver, ISO, and other styles
8

Downey, D. G. "Airways inflammation in cystic fibrosis." Thesis, Queen's University Belfast, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269047.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Evans, Katharine Sarah Emily. "Cystic Fibrosis and the eye." Thesis, Cardiff University, 2009. http://orca.cf.ac.uk/54848/.

Full text
Abstract:
Cystic Fibrosis (CF) results from the defective function of CF Transmembrane Conductance Regulator (CFTR), an ion channel which facilitates epithelial chloride secretion. Previous observations of dry eye and abnormal visual function in CF subjects have been considered secondary manifestations due to associated vitamin A deficiency (VAD) and CF-related diabetes (CFRD). However, CFTR is fundamentally present in the corneal, conjunctival and retinal pigment epithelium and the corneal endothelium. The hypothesis for this thesis was that abnormal chloride secretion in CF causes reduced basal tear secretion and abnormal photoreceptor function: these investigations aimed to identify primary and secondary ocular manifestations of CF. Fluorescein tear break-up time was significantly reduced in adult CF subjects compared to healthy controls. Increased signs of ocular surface inflammation and higher tear feming grades were recorded in CF subjects, although differences failed to reach significance. Tear film stability was further reduced in CF adults with VAD suggesting the aetiology of dry eye appears to be a combination of primary and secondary manifestations of the disease. Visual function was essentially normal in CF juveniles but was adversely affected in CF adults compared to controls. Impaired distance and near visual acuity (DVA and NVA), contrast sensitivity (CS), dark adaptation (DA) and colour vision (CV) appeared to be a primary manifestation as differences were exaggerated in subjects with predicted increased levels of CFTR disruption and disease severity. These results provide support for the hypothesis and suggest normal rod and cone photoreceptor function are compromised by abnormal CFTR action. DVA, NVA, CS and DA were significantly affected by CFRD status and DA and CV were similarly reduced in VAD subjects. Therefore, abnormal visual function in CF is further modulated by secondary disease characteristics. These findings present the distinction between primary and secondary ocular manifestations of CF, which is novel to this investigation.
APA, Harvard, Vancouver, ISO, and other styles
10

Wright, Adam. "The macrophage in cystic fibrosis." Thesis, University of Leicester, 2007. http://hdl.handle.net/2381/8783.

Full text
Abstract:
Background: Cystic fibrosis (CF) is caused by absent/defective CF transmembrane conductance regulator protein (CFTR). CF is characterized by thick airway mucus, chronic infection and neutrophil inflammation leading to respiratory failure. I analysed airway macrophages (MΦs) and their expression of pattern recognition receptors (PRRs) in CF, since these cells are crucial to airway immune defence and they can orchestrate inflammation. I also performed transcript analysis of CF monocyte-derived MΦs (MDMs). Methods: Sputum was induced in CF paediatric and adult cohorts. Phenotype and function of CF MΦ were determined by flow cytometry and compared to controls. Monocytes (>92% purity) were grown in vitro to generate MDMs (n=15). Transcripts encoding the entire human genome were analysed (n=5) and expression of individual genes were confirmed by RT-PCR. Results: In classical CF (n=10) there was an increase in the proportion of monocyte-like small MΦs (of total MΦ) compared to controls (n=10) (73 ± 18% and 16 ± 8%, respectively, p< 0.0001). In non-classical CF (n=4), with milder lung disease, small MΦs increased to 31 ± 20% (p>0.05). PRRs were absent on small MΦs from CF and control. In contrast, clear expression could be detected on large MΦs from control but not CF. In line with this, CF small MΦs showed a strongly reduced uptake of particles compared to controls. Microarray analysis of MDMs revealed α- and β-tryptase as being significantly higher under constitutive and stimulated conditions in CF compared to control. However, using RT-PCR, expression of α- and β-tryptase was similar between groups. Conclusions: The phenotype of small MΦs in CF suggests that these cells are newly recruited monocytes from blood. Low expression of PRRs on these cells in CF and their reduced uptake indicates a reduced capacity to clear inhaled particles, which may contribute to further damage in CF. Further to this I was unable to confirm any transcript differences between CF and control MDMs due to mutant CFTR.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Cystic fibrosis"

1

Silverstein, Alvin. Cystic fibrosis. New York: F. Watts, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Davis, Stephanie Duggins, Margaret Rosenfeld, and James Chmiel, eds. Cystic Fibrosis. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-42382-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Moss, Richard B., ed. Cystic Fibrosis. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0475-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Amaral, Margarida D., and Karl Kunzelmann, eds. Cystic Fibrosis. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-117-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Amaral, Margarida D., and Karl Kunzelmann, eds. Cystic Fibrosis. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-120-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gold, Susan Dudley. Cystic fibrosis. New York: Crestwood House, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

B, Davis Pamela, ed. Cystic fibrosis. New York: M. Dekker, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

1951-, Goodfellow P., ed. Cystic fibrosis. Oxford: Oxford University Press, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

B, Fiel Stanley, ed. Cystic fibrosis. Philadelphia: Saunders, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

E, Hodson Margaret, Geddes Duncan M, and Bush, Andrew, 1954 Apr. 24-, eds. Cystic fibrosis. 3rd ed. London: Hodder Arnold, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Cystic fibrosis"

1

Moss, Richard B. "Introduction." In Cystic Fibrosis, v—ix. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0475-6_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tepper, Robert S., and Howard Eigen. "Airway Reactivity in Cystic Fibrosis." In Cystic Fibrosis, 159–68. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0475-6_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Spino, Michael. "Pharmacokinetics of Drugs in Cystic Fibrosis." In Cystic Fibrosis, 169–210. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0475-6_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Moss, Richard B. "Drug Allergy in Cystic Fibrosis." In Cystic Fibrosis, 211–29. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0475-6_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lewiston, Norman, Vaughn Starnes, and James Theodore. "Heart-Lung and Lung Transplantation for Cystic Fibrosis." In Cystic Fibrosis, 231–47. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0475-6_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wine, Jeffrey J. "Basic Aspects of Cystic Fibrosis." In Cystic Fibrosis, 1–28. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0475-6_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wilmott, Robert W. "The Relationship Between Atopy and Cystic Fibrosis." In Cystic Fibrosis, 29–46. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0475-6_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sorensen, Ricardo U., Robert L. Waller, and Jeffrey D. Klinger. "Infection and Immunity to Pseudomonas." In Cystic Fibrosis, 47–74. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0475-6_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Greenberg, David P., and Harris R. Stutman. "Infection and Immunity to Staphylococcus aureus and Haemophilus influenzae." In Cystic Fibrosis, 75–86. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0475-6_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Prober, Charles G. "The Impact of Respiratory Viral Infections in Patients with Cystic Fibrosis." In Cystic Fibrosis, 87–102. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0475-6_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cystic fibrosis"

1

Škrbic, Dusan, Mirna Djuric, Jelena Papovic, and Branislav Tusek. "COVID-19 vaccine and morbidity in the Adult Cystic Fibrosis Centre in Institute for Pulmonary Diseases of Vojvodina Sremska Kamenica, Serbia." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.47.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Petrova, Guergana, Mila Baycheva, Dimitrinka Miteva, Vera Papochieva, Margarita Nikolova, Miglena Georgieva, Nadezhda Yaneva, and Savov Alexey. "Late diagnosed homozygous delF508 patients - is it really rare?" In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Remus, Natascha, Gaetan Leignadier, Elisa Thomas, Celine Delestrain, Michael Shum, Bernard Maitre, Ralph Epaud, and Benoit Douvry. "The A-Step - a new incremental exercise test defying space and infection control measures." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Duplacie, Nele, Trudy Havermans, Janne Houben, Marianne Schulte, Linda Boulanger, Laura Moyens, Cindy Ruelens, and Lieven Dupont. "Side-effects and ETI-treatment: a multidisciplinary challenge." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Daniels, Tanne, Kristel Van Calsteren, and Lieven Dupont. "Maternal and obstetric outcomes in women with cystic fibrosis: a retrospective case series of patients in UZ Leuven." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Skogeland, Ulrika, Anna Hedborg, Cecilia Rodriguez, Adrienn Bánki, and Tove Godskesen. "Adherence to medical regimens after lung transplantation among adults with Cystic Fibrosis increased during COVID-19 pandemic." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Asir, Nadine, Noor Al-Sulaiti, Abdusamea Shabani, and Atqah Abdul Wahab. "First case of pott's disease in a cystic fibrosis adolescent with a homozygous CFTR mutation c.3700 A > G (p. Ile1234Val)." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Momchilovikj, Sonja, Dejan Dokic, Sava Pejkovska, Smiljko Jovanoski, Dimitar Karkinski, Zoran Arsovski, Stojka Naceva-Fustik, et al. "Initial experiences in treatment with modulatory therapy in patients with Cystic Fibrosis in North Macedonia." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.39.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Baxter, Gabrielle, Ashkan Pakzad, Bojidar Rangelov, Shayan Shaikh, Ying Xin Tan, Robert Chapman, Daniel Peckham, and Joseph Jacob. "Quantitative computed tomography measures of disease severity in cystic fibrosis." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.35.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Alyami, Mohammad Hussain. "Middle east respiratory syndrome (MERS) and novel coronavirus disease-2019 (COVID-19) from causes to preventions in Saudi Arabia." In Adult Cystic Fibrosis Conference abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/23120541.acf-2023.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Cystic fibrosis"

1

Garber, Alan, and Joseph Fenerty. Costs and Benefits of Prenatal Screening For Cystic Fibrosis. Cambridge, MA: National Bureau of Economic Research, October 1988. http://dx.doi.org/10.3386/w2749.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Barros-Poblete, Marisol, Rodrigo Torres-Castro, Mauricio Henríquez, Anita Guequen, Isabel Blanco, and Carlos Flores. Dysbiosis as a prognostic factor for clinical worsening in chronic respiratory disease: A systematic review and metanalysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0089.

Full text
Abstract:
Review question / Objective: Is dysbiosis a prognostic factor for clinical worsening in patients with chronic respiratory diseases?. Condition being studied: Dysbiosis, defined as changes in the quantitative and qualitative composition of the microbiota. Eligibility criteria: Over 18 years old adult patients with chronic respiratory diseases clinical diagnosis (cystic fibrosis, chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, interstitial lung disease, sarcoidosis, bronchiectasis, non-CF bronchiectasis, pulmonary hypertension) according to the International Statistical Classification of Diseases and Related Health Problems (ICD) from OMS) and international guidelines of each disease.
APA, Harvard, Vancouver, ISO, and other styles
3

Taub, Daniel, and Joshua Page. Cystic Fibrosis: Exploration of Evolutionary Explanations for the High Frequency of a Common Genetic Disorder. Genetics Society of America Peer-Reviewed Education Portal (GSA PREP), October 2013. http://dx.doi.org/10.1534/gsaprep.2013.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Borisova, Dayana, Tanya Strateva, Tsvetelina Paunova-Krasteva, Ivan Mitov, and Stoyanka Stoitsova. Phenotypic Investigation of Paired Pseudomonas aeruginosa Strains Isolated from Cystic Fibrosis Patients Prior- and Post-tobramycin Treatment. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, August 2018. http://dx.doi.org/10.7546/crabs.2018.08.05.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jangir, Hemlata, Aparna Ningombam, Arulselvi Subramanian, and Subodh Kumar. Traumatic Jejunal Mesenteric Pseudocyst in the Vicinity of Blunt Abdominal Trauma with a Brief Review of Literature. Science Repository, January 2023. http://dx.doi.org/10.31487/j.ajscr.2022.04.04.

Full text
Abstract:
Mesenteric pseudocyst (MP) is a rare heterogeneous group of intra-abdominal benign cystic lesions with different etiopathogenesis and clinically silent behaviours. These lesions are introduced as one of the entities based on the histological features of thick fibrous cyst walls, barren of the epithelial lining. Often, they present as expanding abdominal masses or are diagnosed incidentally in conventional radiological studies, exploratory laparotomies, or with symptoms of complications such as infection, torsion, or rupture. Surgical removal of the cyst, with or without resection of the affected intestinal segment, is the treatment of choice. Depending upon the size and location of the lesion and related complications, it can be managed by open surgical procedures or laparoscopic approach. Only a handful of 7 cases of traumatic mesenteric cysts have been reported yet in the vicinity of blunt abdominal trauma. We report a rare incidentally detected case of mesenteric pseudocyst (traumatic) in a male of early 20s with a history of blunt abdominal trauma 13 months back and for which serial abdominal exploratory laparotomies were performed. A brief review of the literature is provided, conforming to the rarity of the case. This case highlights the role of histomorphology in diagnosing a benign cystic entity with accuracy, that could be misdiagnosed as infectious granulomatous lesion.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Cystic fibrosis' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography